Study of MI226 injection for belly fat
Part of Hormones & metabolism clinical trials.
This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- Your body mass index (BMI) is between 19 and 37.
- You have enough belly fat that the doctor can see and feel it.
- You are willing to use birth control and not donate sperm or eggs for 3 months after the last dose.
- You agree to follow the study rules and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational injection called MWN109 to help adults with overweight or obesity lose weight. It is a phase 3 study, meaning it is being tested in a large group of people to see how well it works and if it is safe.
This study tests an investigational injection (JMT206) in people with obesity. The goal is to see if the medicine is safe and tolerable when given multiple times; it may help with weight management in the future.
This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.
This study tests an injection called CBL-514 that may help reduce belly fat. It is for adults with extra abdominal fat who want a non-surgical option.
This trial tests a new injection called CBL-514 that is designed to reduce fat under the skin in the belly area. It might help people who are dissatisfied with stubborn abdominal fat that doesn't go away with diet and exercise.
This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.
Hear when a new Abdominal Fat trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.